June 16, 2020
Taiho Pharmaceutical on June 15 filed an application with the Japanese health ministry, seeking approval for an additional dosage and administration for the pediatric use of its antiemetic agent Aloxi (palonosetron). Taiho, an Otsuka Holdings subsidiary, has Japan rights for...read more